Compare RCUS & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | RHI |
|---|---|---|
| Founded | 2015 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2018 | 1994 |
| Metric | RCUS | RHI |
|---|---|---|
| Price | $24.87 | $27.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $31.90 | $30.33 |
| AVG Volume (30 Days) | 1.3M | ★ 2.7M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $247,000,000.00 | ★ $5,378,506,000.00 |
| Revenue This Year | N/A | $1.27 |
| Revenue Next Year | $45.62 | $5.95 |
| P/E Ratio | ★ N/A | $187.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.92 | $21.83 |
| 52 Week High | $28.72 | $48.54 |
| Indicator | RCUS | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 53.55 |
| Support Level | $23.91 | $25.93 |
| Resistance Level | $28.72 | $28.35 |
| Average True Range (ATR) | 1.81 | 1.36 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 55.67 | 41.42 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.